|
|
Article: Genesis Bioventures Signs Exclusive Agreement to Commercialize Mad Cow Disease Rapid Test in Pacific Rim.
- Article from:
- PR Newswire
- Article date:
- June 16, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK, June 16 /PRNewswire-FirstCall/ -- Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that it has granted an exclusive license to Bio Business Development Company (BBDC) to commercialize the Rapid Prion Detection Assays in eighteen countries of the Pacific Rim. The licensed technology has been developed by Prion Developmental Laboratories (PDL), a portfolio company of GBI.
GBI has the exclusive, worldwide sales, marketing and distribution rights to commercialize the recently patented Rapid Prion Detection Assays, including rapid tests for Bovine Spongiform Encephalopathy (BSE or mad cow disease) in cattle and scrapie in sheep. With the ...